Effect of levitra on sustenance of erection (EROS): an open-label, prospective, multicenter, single-arm study to investigate erection duration measured by stopwatch with flexible dose vardenafil administered for 8 weeks in subjects with erectile dysfunction

Article metrics

Subjects

Abstract

To investigate the change of erection duration measured by stopwatch with flexible dose vardenafil administered for 8 weeks in subjects with erectile dysfunction (ED). Effect of levitra on sustenance of erection was an open-label, prospective, multicenter and single-arm study designed to measure the duration of erection in men with ED receiving a flexible dose of vardenafil over an 8-week treatment period. Patients were instructed to take vardenafil 10 mg 60 min before attempting the intercourse. Vardenfil could be increased to 20 mg or decreased to 5 mg concerning patients' efficacy and safety. Following the initial screening, patients entered a 4-week treatment-free run-in phase and 8-week treatment period, during which they were instructed to attempt intercourse at least four times on four separate days. A total of 95 men were enrolled in 10 centers. After the 8 weeks treatment, the mean duration of erection leading to successful intercourse was statistically superior when patients were treated with vardenafil. After an 8-week treatment, the duration of erection leading to successful intercourse was 9.39 min. There were significant benefits with vardenafil in all domains of International Index of Erectile Function. Secondary efficacy end points included success rate of penetration, maintaining erection, ejaculation and satisfaction were superior when patients were treated with vardenafil. There was a significant correlation between duration of erection with other sexual factors. Also partner's sexual satisfaction was increased with vardenafil. Most adverse events were mild or moderate in severity. Vardenafil was safe and well tolerated. Vardenafil therapy provided a statistically superior duration of erection leading to successful intercourse in men with ED with female partner.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. JAMA 1994; 272: 1942

  2. 2

    Bener A, Al-Hamaq AO, Kamran S, Al-Ansari A . Prevalence of erectile dysfunction in male stroke patients, and associated co-morbidities and risk factors. Int Urol Nephrol 2008; 40: 701

  3. 3

    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54

  4. 4

    Mulhall J, King R, Glina S, Hvidsten K . Importance of and satisfaction with sex among men and women worldwide: results of the global better sex survey. J Sex Med 2008; 5: 788

  5. 5

    Chevret M, Jaudinot E, Sullivan K, Marrel A, De Gendre AS . Impact of erectile dysfunction (ED) on sexual life of female partners: assessment with the Index of Sexual Life (ISL) questionnaire. J Sex Marital Ther 2004; 30: 157.

  6. 6

    Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I . Sexual experience of female partners of men with erectile dysfunction: the female experience of men’s attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675.

  7. 7

    Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J et al. EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006; 49: 806.

  8. 8

    Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P et al. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005; 2: 699.

  9. 9

    Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763.

  10. 10

    Ralph D, Eardley I, Kell P, Dean J, Hackett G, Collins O et al. Improvement in erectile function on vardenafil treatment correlates with treatment satisfaction in both patients and their partners. BJU Int 2007; 100: 130.

  11. 11

    Rosen R, Shabsigh R, Berber M, Assalian P, Menza M, Rodriguez-Vela L et al. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study. Am J Psychiatry 2006; 163: 79.

  12. 12

    Stief C, Porst H, Saenz De Tejada I, Ulbrich E, Beneke M . Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract 2004; 58: 230.

  13. 13

    Cheng E . Real-life safety and efficacy of vardenafil in the treatment of erectile dysfunction results from 30,010 U.S. patients. J Sex Med 2007; 4: 432.

  14. 14

    Eardley I, Lee JC, Shabsigh R, Dean J, Maggi M, Neuser D et al. Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications. J Sex Med 2010; 7: 244.

  15. 15

    Edwards D, Hackett G, Collins O, Curram J . Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo controlled trial in PDE5 inhibitor-naive men with ED and their partners. J Sex Med 2006; 3: 1028.

  16. 16

    Rosenberg MT, Adams PL, McBride TA, Roberts JN, McCallum SW . Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study. Int J Clin Pract 2009; 63: 27.

  17. 17

    Miner M, Gilderman L, Bailen J, Cook D, Dawson K, Stanislaus M et al. Vardenafil in men with stable statin therapy and dyslipidemia. J Sex Med 2008; 5: 1455.

  18. 18

    Fugl-Meyer KS . Erectile problems: the perspective of the female. Scand J Urol Nephrol 1998; 32: 12.

Download references

Acknowledgements

This study was sponsored by Bayer Healthcare (study no., DURA KR01).

Author information

Correspondence to J K Park.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Author contributions

YSS and JKP were involved in the data collection, and analysis and description of the paper. SWL, KP, WSC, SWK, JSH, DGM, S-KY, JKR, DYY, KHM, KSM and JKP were involved in the preparation of the protocol of clinical trial, performed the trial and reviewed the manuscript.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shin, Y., Lee, S., Park, K. et al. Effect of levitra on sustenance of erection (EROS): an open-label, prospective, multicenter, single-arm study to investigate erection duration measured by stopwatch with flexible dose vardenafil administered for 8 weeks in subjects with erectile dysfunction. Int J Impot Res 27, 95–102 (2015) doi:10.1038/ijir.2014.39

Download citation

Further reading